Relationship between HbA1c and coronary flow rate in patients with type 2 diabetes mellitus and angiographically normal coronary arteries

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 6, 2010, Pages 405-410

  Yilmaz, Mehmet Birhan ^a   Erdem, Alim ^b   Yontar, Osman Can ^b   Sarikaya, Savaş ^c   Yilmaz, Ahmet ^a   Madak, Nihat ^d   Karadaş, Filiz ^e   Tandog, Izzet ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Sivas Devlet Hastanesi   (Turkey)

^c Mus State Hospital   (Turkey)

^d Turgutlu State Hospital   (Turkey)

^e Aydin State Hospital   (Turkey)

Author keywords

Blood flow velocity; Coronary circulation; Diabetes mellitus, type 2 complications; Endothelium, vascular; Hemoglobin A, glycosylated; Hyperglycemia complications

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; FEMALE; HUMAN; IMAGE ANALYSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RIGHT CORONARY ARTERY; ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ECHOCARDIOGRAPHY; ECHOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY;

ADULT; AGED; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 79960002401     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998;98: 398-404. (Pubitemid 28357941)
2. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year followup. Diabetologia 1991;34:356-61.
3. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7. (Pubitemid 26114161)
4. Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl 1997;62:S23-8.
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
7. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.
8. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996;37:375-81. (Pubitemid 26100780)
9. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-72.
10. Sezgin AT, Siǧirci A, Barutçu I, Topal E, Sezgin N, Özdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003;14:155-61. (Pubitemid 36543418)
11. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J 1972;84:66-71.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31 Suppl 1:S55-60.
13. Yilmaz MB, Yalta K. Coronary flow slows as renal function worsens. Clin Cardiol 2009;32:278-82.
14. Waters D, Higginson L, Gladstone P, Kimball B, LeMay M, Lespérance J. Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Canada. Control Clin Trials 1993;14:45-74. (Pubitemid 23065896)
15. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88. (Pubitemid 26074824)
16. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;1:1373-6. (Pubitemid 10069461)
17. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994;43:836-41. (Pubitemid 24166362)
18. Rogers WJ, Russell RO Jr, McDaniel HG, Rackley CE. Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am J Cardiol 1977;40:421-8. (Pubitemid 8184786)
19. Laine H, Nuutila P, Luotolahti M, Meyer C, Elomaa T, Koskinen P, et al. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. J Clin Endocrinol Metab 2000;85: 1868-73. (Pubitemid 32269291)
20. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-99.
21. Steiner G. The dyslipoproteinemias of diabetes. Atherosclerosis 1994;110 Suppl:S27-33.
22. Li JJ, Fang CH. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis. Med Hypotheses 2004;63:100-2.
23. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 2004;62:499-506.
24. Shah PK. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation 2003;107:2175-7. (Pubitemid 36547207)
25. Li JJ. Inflammation: an important mechanism for different clinical entities of coronary artery diseases. Chin Med J 2005;118:1817-26.
26. Turhan H, Saydam GS, Erbay AR, Ayaz S, Yasar AS, Aksoy Y, et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 2006; 108:224-30. (Pubitemid 43330618)
27. Corpus RA, O'Neill WW, Dixon SR, Timmis GC, Devlin WH. Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003;92:1282-6. (Pubitemid 37431135)
28. Tooke JE. Microvasculature in diabetes. Cardiovasc Res 1996;32:764-71. (Pubitemid 26332315)
29. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, et al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997;40:619-28. (Pubitemid 27288105)
30. Burckhartt BA, Mukerji V, Alpert MA. Coronary artery slow flow associated with angina pectoris and hypotension-a case report. Angiology 1998;49:483-7. (Pubitemid 28275204)
31. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ, et al. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007;30:2729-36. (Pubitemid 47547828)
32. Pekdemir H, Cin VG, Çiçek D, Camsari A, Akkuş N, Döven O, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004;59:127-33.